Centene Corp. reaches $13.7M settlement with New Mexico over pharmacy benefit practices


New Mexico is the latest state where Centene Corp. has reached a settlement over an investigation into its pharmacy benefit management practices for the Medicaid program.

Previous Peninsula biotech looks to raise $144M after childhood brain cancer data, big stock jump
Next Sales of over-the-counter hearing aids await final FDA rule